Phase I clinical trials (Drug development) Archives

The concept of dna the study of molecules .

News & Features

Leapfrog Bio Screens Clinical Stage Drugs to Jump into Cancer Markets

Jonathan D. Grinstein, PhD -

September 10, 2024

News & Features

Roche Oral GLP-1 Agonist Scores in Early Trial

Malorye Branca -

July 19, 2024

Cancer cell surrounded by therapeutic antibodies and cytokines among normal cells

News & Features

Vertex and Orum Launch $945M+ Collaboration to Replace Chemotherapy with DAC

Alex Philippidis -

July 17, 2024

Human kidney cross section on scientific background

News & Features

Microbiome Pill Could Boost Kidney Cancer Responses

Malorye Branca -

July 1, 2024

Genomenon said today it has partnered with Rhythm Pharmaceuticals to create a database of genetic mutations associated with obesity as documented in published studies. Rhythm plans to use the data to better understand rare genetic disorders of obesity. [Visual Mozart/Getty Images]

News & Features

Metsera Launches with $290M to Develop Next Generation Weight Loss Products

Malorye Branca -

April 22, 2024

Illustration showing a pancreas with pancreatic cancer highlighted in red.

News & Features

Investigational mRNA-Based Vaccine May Represent New Approach to Treating Pancreatic Cancer

Chris Anderson -

April 8, 2024

News & Features

Gilead and Xilio Ink Potential $640M+ Deal around “Next-Generation” Immunotherapy

Malorye Branca -

April 3, 2024

woman holding her wrist pain because using smartphone or computer long time. De Quervain's tenosynovitis, Intersection Symptom, Carpal Tunnel Syndrome or Office syndrome concept. To illustrate tendon damage

News & Features

Next-Generation Non-Opioid Pain Relievers Advance

Malorye Branca -

February 15, 2024

Rapamycin inhibiting protein kinase mTORC1

News & Features

First MYC Inhibitor Shows Promise in Human Clinical Trial

Alisa Kirkin -

February 7, 2024

Nutritionist calculating body mass index of woman for obesity treatment in a clinic room. Mutations in the TRPC5 gene can cause obesity and postpartum depression.

News & Features

Amgen’s Weight Loss Candidate Shines in Phase I Study

Malorye Branca -

February 6, 2024

12 3 4 Page 1 of 4

Better Heart Health Early on May Offset Risk of Pregnancy-Related Hypertension

Five Features Underlie Immunotherapy Response

Antibiotic Use Linked to Increased Risk of Inflammatory Bowel Disease

33 Zeroes: Verseon Advances AI Accuracy for Novel Small Molecule Designs

New Tool Predicts Severity of TNBC

Phase I clinical trials (Drug development)

Leapfrog Bio Screens Clinical Stage Drugs to Jump into Cancer Markets

Roche Oral GLP-1 Agonist Scores in Early Trial

Vertex and Orum Launch $945M+ Collaboration to Replace Chemotherapy with DAC

Microbiome Pill Could Boost Kidney Cancer Responses

Metsera Launches with $290M to Develop Next Generation Weight Loss Products

Investigational mRNA-Based Vaccine May Represent New Approach to Treating Pancreatic Cancer

Gilead and Xilio Ink Potential $640M+ Deal around “Next-Generation” Immunotherapy

Next-Generation Non-Opioid Pain Relievers Advance

First MYC Inhibitor Shows Promise in Human Clinical Trial

Amgen’s Weight Loss Candidate Shines in Phase I Study

Related Content

Five Features Underlie Immunotherapy Response

Cancer Trials Exclude Individuals of African and Middle Eastern Ancestry Due to Duffy Blood Group

Nano Delivery of Drug Combo Shrinks Pancreatic Cancer Tumors in Mice

Olaparib Monotherapy: A Promising Option for Biochemically Recurrent Prostate Cancer?